{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2019:WBI3XQFJQCPIT636OCB72JPWPU","short_pith_number":"pith:WBI3XQFJ","canonical_record":{"source":{"id":"1905.12033","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.QM","submitted_at":"2019-05-28T19:03:02Z","cross_cats_sorted":["cs.LG"],"title_canon_sha256":"82a205dae18d5cfe73d863f29214def18d41dad43e0aeb3c19ea68855313c7b3","abstract_canon_sha256":"ec2490fd459403e067850e5d22542afc83dd23601808ab3eea685d62581ab8ed"},"schema_version":"1.0"},"canonical_sha256":"b051bbc0a9809e89fb7e7083fd25f67d1310ddc6752d181c4df9c01fed5489e9","source":{"kind":"arxiv","id":"1905.12033","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1905.12033","created_at":"2026-05-17T23:44:49Z"},{"alias_kind":"arxiv_version","alias_value":"1905.12033v1","created_at":"2026-05-17T23:44:49Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1905.12033","created_at":"2026-05-17T23:44:49Z"},{"alias_kind":"pith_short_12","alias_value":"WBI3XQFJQCPI","created_at":"2026-05-18T12:33:30Z"},{"alias_kind":"pith_short_16","alias_value":"WBI3XQFJQCPIT636","created_at":"2026-05-18T12:33:30Z"},{"alias_kind":"pith_short_8","alias_value":"WBI3XQFJ","created_at":"2026-05-18T12:33:30Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2019:WBI3XQFJQCPIT636OCB72JPWPU","target":"record","payload":{"canonical_record":{"source":{"id":"1905.12033","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.QM","submitted_at":"2019-05-28T19:03:02Z","cross_cats_sorted":["cs.LG"],"title_canon_sha256":"82a205dae18d5cfe73d863f29214def18d41dad43e0aeb3c19ea68855313c7b3","abstract_canon_sha256":"ec2490fd459403e067850e5d22542afc83dd23601808ab3eea685d62581ab8ed"},"schema_version":"1.0"},"canonical_sha256":"b051bbc0a9809e89fb7e7083fd25f67d1310ddc6752d181c4df9c01fed5489e9","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-17T23:44:49.177964Z","signature_b64":"7YBX/21bxHNKE9JPtR4rD34JVSuWuYI4OEm3rddoHnYhvGQzHNPTG0HELwNH0CIDdoif05+yXLbFmpkuh+jDBg==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"b051bbc0a9809e89fb7e7083fd25f67d1310ddc6752d181c4df9c01fed5489e9","last_reissued_at":"2026-05-17T23:44:49.177490Z","signature_status":"signed_v1","first_computed_at":"2026-05-17T23:44:49.177490Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1905.12033","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-17T23:44:49Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"AHEyYxk7rzx3xf2pwvZr9bQ7U4vLhv+AIejASzNKm9+EFoMg8i3Ojxnnb8wf52mzOArdyW5JhMz2FErKjvqYCQ==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-12T09:34:08.334181Z"},"content_sha256":"deeff781669daa69d98b9f2c02dea7ad56ed65c2eea1aa140b5d7146e5cbcd47","schema_version":"1.0","event_id":"sha256:deeff781669daa69d98b9f2c02dea7ad56ed65c2eea1aa140b5d7146e5cbcd47"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2019:WBI3XQFJQCPIT636OCB72JPWPU","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Leveraging binding-site structure for drug discovery with point-cloud methods","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":["cs.LG"],"primary_cat":"q-bio.QM","authors_text":"Carlos G. Oliver, Jerome Waldispuhl, Nicolas Moitessier, Vincent Mallet","submitted_at":"2019-05-28T19:03:02Z","abstract_excerpt":"Computational drug discovery strategies can be broadly placed in two categories: ligand-based methods which identify novel molecules by similarity with known ligands, and structure-based methods which predict molecules with high-affinity to a given 3D structure (e.g. a protein). However, ligand-based methods do not leverage information about the binding site, and structure-based approaches rely on the knowledge of a finite set of ligands binding the target. In this work, we introduce TarLig, a novel approach that aims to bridge the gap between ligand and structure-based approaches. We use the "},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1905.12033","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-17T23:44:49Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"R7fb43XYz71IEhuV6GTxE+l375MTQXkWWGJYIIT5YxT7RSfzds5ubanDt5l4/JeHIrJpyHd0T5nZAp4+j/87DA==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-12T09:34:08.334850Z"},"content_sha256":"6cf92d7309dfe571b5d64acda26e8f02a2593a19327ab4646e0291f4044bf1ec","schema_version":"1.0","event_id":"sha256:6cf92d7309dfe571b5d64acda26e8f02a2593a19327ab4646e0291f4044bf1ec"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/WBI3XQFJQCPIT636OCB72JPWPU/bundle.json","state_url":"https://pith.science/pith/WBI3XQFJQCPIT636OCB72JPWPU/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/WBI3XQFJQCPIT636OCB72JPWPU/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-08-12T09:34:08Z","links":{"resolver":"https://pith.science/pith/WBI3XQFJQCPIT636OCB72JPWPU","bundle":"https://pith.science/pith/WBI3XQFJQCPIT636OCB72JPWPU/bundle.json","state":"https://pith.science/pith/WBI3XQFJQCPIT636OCB72JPWPU/state.json","well_known_bundle":"https://pith.science/.well-known/pith/WBI3XQFJQCPIT636OCB72JPWPU/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2019:WBI3XQFJQCPIT636OCB72JPWPU","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"ec2490fd459403e067850e5d22542afc83dd23601808ab3eea685d62581ab8ed","cross_cats_sorted":["cs.LG"],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.QM","submitted_at":"2019-05-28T19:03:02Z","title_canon_sha256":"82a205dae18d5cfe73d863f29214def18d41dad43e0aeb3c19ea68855313c7b3"},"schema_version":"1.0","source":{"id":"1905.12033","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1905.12033","created_at":"2026-05-17T23:44:49Z"},{"alias_kind":"arxiv_version","alias_value":"1905.12033v1","created_at":"2026-05-17T23:44:49Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1905.12033","created_at":"2026-05-17T23:44:49Z"},{"alias_kind":"pith_short_12","alias_value":"WBI3XQFJQCPI","created_at":"2026-05-18T12:33:30Z"},{"alias_kind":"pith_short_16","alias_value":"WBI3XQFJQCPIT636","created_at":"2026-05-18T12:33:30Z"},{"alias_kind":"pith_short_8","alias_value":"WBI3XQFJ","created_at":"2026-05-18T12:33:30Z"}],"graph_snapshots":[{"event_id":"sha256:6cf92d7309dfe571b5d64acda26e8f02a2593a19327ab4646e0291f4044bf1ec","target":"graph","created_at":"2026-05-17T23:44:49Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"Computational drug discovery strategies can be broadly placed in two categories: ligand-based methods which identify novel molecules by similarity with known ligands, and structure-based methods which predict molecules with high-affinity to a given 3D structure (e.g. a protein). However, ligand-based methods do not leverage information about the binding site, and structure-based approaches rely on the knowledge of a finite set of ligands binding the target. In this work, we introduce TarLig, a novel approach that aims to bridge the gap between ligand and structure-based approaches. We use the ","authors_text":"Carlos G. Oliver, Jerome Waldispuhl, Nicolas Moitessier, Vincent Mallet","cross_cats":["cs.LG"],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.QM","submitted_at":"2019-05-28T19:03:02Z","title":"Leveraging binding-site structure for drug discovery with point-cloud methods"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1905.12033","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:deeff781669daa69d98b9f2c02dea7ad56ed65c2eea1aa140b5d7146e5cbcd47","target":"record","created_at":"2026-05-17T23:44:49Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"ec2490fd459403e067850e5d22542afc83dd23601808ab3eea685d62581ab8ed","cross_cats_sorted":["cs.LG"],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.QM","submitted_at":"2019-05-28T19:03:02Z","title_canon_sha256":"82a205dae18d5cfe73d863f29214def18d41dad43e0aeb3c19ea68855313c7b3"},"schema_version":"1.0","source":{"id":"1905.12033","kind":"arxiv","version":1}},"canonical_sha256":"b051bbc0a9809e89fb7e7083fd25f67d1310ddc6752d181c4df9c01fed5489e9","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"b051bbc0a9809e89fb7e7083fd25f67d1310ddc6752d181c4df9c01fed5489e9","first_computed_at":"2026-05-17T23:44:49.177490Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-17T23:44:49.177490Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"7YBX/21bxHNKE9JPtR4rD34JVSuWuYI4OEm3rddoHnYhvGQzHNPTG0HELwNH0CIDdoif05+yXLbFmpkuh+jDBg==","signature_status":"signed_v1","signed_at":"2026-05-17T23:44:49.177964Z","signed_message":"canonical_sha256_bytes"},"source_id":"1905.12033","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:deeff781669daa69d98b9f2c02dea7ad56ed65c2eea1aa140b5d7146e5cbcd47","sha256:6cf92d7309dfe571b5d64acda26e8f02a2593a19327ab4646e0291f4044bf1ec"],"state_sha256":"92d2279a605cef48e84dc120dd09ddf9ba5965468ec2d77db7ca0ce49e64d95c"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"MfrPG6kGISvQdzc84ITtF0Hb6j64kE9zJNz3ufQbkSgY4PvY//jFqvvnp3bP6mexfjqS1gBWW5yo7/tXvrJsDQ==","signed_message":"bundle_sha256_bytes","signed_at":"2026-08-12T09:34:08.338808Z","bundle_sha256":"8b49012737e871a338a02911acb793df15a9a5c331b1701f97dcabf069832efd"}}